Exploring the Correlation between Serum Vitamin D Levels and Cancer Stage and Grading in Pediatric Patients | ||
Journal of Pediatric Perspectives | ||
دوره 12، شماره 11، بهمن 2024، صفحه 19152-19157 اصل مقاله (301.58 K) | ||
نوع مقاله: original article | ||
شناسه دیجیتال (DOI): 10.22038/jpp.2024.80999.5463 | ||
نویسندگان | ||
Motahareh Aghajani Delavar1؛ Niyousha Zargari2؛ Hamidreza Khoshnezhad* 3؛ Shabahang Jafarnejad3؛ Asma Javid4 | ||
1Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Aliasghar Children Hospital, Tehran, Iran. | ||
2Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. | ||
3Department of Emergency Medicine, School of Medicine, Iran University of Medical Sciences, Aliasghar Children Hospital, Tehran, Iran. | ||
4Department of Pediatric Intensive Care, Iran University of Medical Sciences, Tehan, Iran. | ||
چکیده | ||
Background: Vitamin D deficiency has been linked to an elevated risk of cancer and poor outcomes. This study was conducted to explore the potential impact of vitamin D status on cancer progression and severity in pediatric patients. Methods: The current study adopted a case-control design to investigate the relationship between serum vitamin D levels and cancer stage and grading in pediatric patients. The case group comprised newly diagnosed cases of children and adolescents with various types of cancer admitted to Ali Asghar Hospital between 2023 - 2024. Statistical analysis was performed using SPSS software version 24, with a significance level set at less than 0.05. Results: A total of 155 patients were included in the study, with 72 patients in the case group and 86 patients in the control group. Among the participants, 26 (36.1%) and 32 (38.6%) subjects in the case and control groups were girls, respectively. Acute lymphoblastic leukemia (ALL) accounted for 16.1% of the cases, followed by retinoblastoma (5.8%) and acute myeloid leukemia (AML) (4.5%) as the most frequent cancer types observed. Notably, the analysis of vitamin D serum levels revealed no significant difference between the case group (median: 25, range: 76-4) and the control group (median: 27, range: 69.5-12). Furthermore, the comparison of vitamin D serum levels across different cancer stages did not show any significant differences. Conclusion: Our findings show that children with newly diagnosed cancer have 25 (OH) D3 levels identical to their healthy matches. However, the importance of our findings to cancer progression is unclear and needs further investigations. | ||
کلیدواژهها | ||
Cancer؛ Pediatrics؛ Vitamin D؛ 25-hydroxyvitamin D3 | ||
مراجع | ||
| ||
آمار تعداد مشاهده مقاله: 183 تعداد دریافت فایل اصل مقاله: 104 |